Skip to main content

About us

Established in 2014 OLM Diagnostics are leading the development of highly specific and sensitive fungal diagnostic tests to a new standard of testing that delivers rapid, reliable and precise results in real time. Through collaborative efforts with clinical and academic partners we have developed a portfolio of rapid point of care diagnostic tests for medical areas that have long been underserved, bringing much needed solutions to the forefront. Our novel and reliable rapid-diagnostic tests fit seamlessly into current treatment pathways and can reduce the rate of drug resistant infections by promoting a new diagnostic led approach. This is achieved, whilst delivering clear financial and clinical benefits to hospitals, clinicians and patient care.

The benefits of our tests

Current diagnostic testing can be unreliable and time consuming. OLM Diagnostics offers an easy solution that allows clinicians to rapidly identify the exact cause of a patients infection. Our innovative and diagnostic solutions are designed to offer a range of benefits:

  • Our tests are inexpensive and require no additional laboratory equipment.
  • They offer potential costs savings for hospitals; avoiding unnecessary prescriptions and higher costs associated with treating resistant infections.
  • A reduced rate of drug resistant infections.
  • Preservation of existing antifungal medication.
  • Improvement to patient care through appropriate prescribing.

A diagnostic-led approach

Traditional fungal diagnostic tests are slow, unreliable and unspecific. This is leading to delayed diagnosis, misdiagnosis, inappropriate use of antifungal treatment and increased antifungal resistance. A diagnostic led approach will address all of these threats. We are discovering and developing a new diagnostic-led approach to tackling fungal infections. Our research and development drives our company focus; to reinforce our reputation as a trusted healthcare partner and to enhance patient health outcomes.

Clinicians can have confidence in the sensitivity and specificity of our tests – to correctly identify true positive and true negative cases, facilitating the quick and accurate identification of invasive fungal infections to support the use of appropriate antifungal prescribing.

Contact us to find out which of our fungal diagnostic tests would be most appropriate for your patients and hospital settings.

Get in touch

Gemma Johnson, Scientific Director